AU2003291367A1 - Method of treating sepsis-induced ards - Google Patents

Method of treating sepsis-induced ards Download PDF

Info

Publication number
AU2003291367A1
AU2003291367A1 AU2003291367A AU2003291367A AU2003291367A1 AU 2003291367 A1 AU2003291367 A1 AU 2003291367A1 AU 2003291367 A AU2003291367 A AU 2003291367A AU 2003291367 A AU2003291367 A AU 2003291367A AU 2003291367 A1 AU2003291367 A1 AU 2003291367A1
Authority
AU
Australia
Prior art keywords
tetracycline
administered
tetracycline compound
day
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003291367A
Other languages
English (en)
Inventor
Louis Gatto
Lorne M. Golub
Jeff Halter
Hsi-Ming Lee
Charles Lutz
William Marx
Gary Nieman
Anthony Picone
Henry Schiller
Sanford R. Simon
Jay Steinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of AU2003291367A1 publication Critical patent/AU2003291367A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003291367A 2002-11-09 2003-11-07 Method of treating sepsis-induced ards Abandoned AU2003291367A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/291,194 2002-11-09
US10/291,194 US20040092491A1 (en) 2002-11-09 2002-11-09 Method of treating sepsis-induced ARDS
PCT/US2003/035531 WO2004043228A2 (en) 2002-11-09 2003-11-07 Method of treating sepsis-induced ards

Publications (1)

Publication Number Publication Date
AU2003291367A1 true AU2003291367A1 (en) 2004-06-03

Family

ID=32229212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003291367A Abandoned AU2003291367A1 (en) 2002-11-09 2003-11-07 Method of treating sepsis-induced ards

Country Status (8)

Country Link
US (1) US20040092491A1 (enExample)
EP (1) EP1567168A2 (enExample)
JP (1) JP2006508128A (enExample)
KR (1) KR20050084960A (enExample)
AU (1) AU2003291367A1 (enExample)
CA (1) CA2504310A1 (enExample)
NZ (1) NZ540497A (enExample)
WO (1) WO2004043228A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003088906A2 (en) * 2002-04-16 2003-10-30 Collagenex Pharmaceuticals, Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
US20070010498A1 (en) * 2005-07-07 2007-01-11 Klaus Theobald Method for reducing blood loss associated with cardio-pulmonary bypass surgery
RU2014146121A (ru) * 2009-01-12 2015-06-10 Аэрпио Терапьютикс Инк. Способы лечения синдрома сосудистой утечки
US11103628B1 (en) * 2020-04-29 2021-08-31 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US10881781B1 (en) 2020-04-29 2021-01-05 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
WO2022191828A1 (en) * 2021-03-10 2022-09-15 Wen Tan NEW USE OF (R)-β2-AGONISTS IN TREATMENT OF SEPSIS AND ACUTE RESPIRATORY DISTRESS SYNDROME
WO2023133096A1 (en) * 2022-01-04 2023-07-13 The Research Foundation For The State University Of New York Cmt-3 formulations and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003057A1 (en) * 1993-07-20 1995-02-02 Chugai Seiyaku Kabushiki Kaisha Endotoxin neutralizer
US5773430A (en) * 1997-03-13 1998-06-30 Research Foundation Of State University Of New York Serine proteinase inhibitory activity by hydrophobic tetracycline
US5977091A (en) * 1998-09-21 1999-11-02 The Research Foundation Of State University Of New York Method of preventing acute lung injury

Also Published As

Publication number Publication date
NZ540497A (en) 2008-02-29
WO2004043228A3 (en) 2005-04-07
JP2006508128A (ja) 2006-03-09
US20040092491A1 (en) 2004-05-13
EP1567168A2 (en) 2005-08-31
CA2504310A1 (en) 2004-05-27
WO2004043228A2 (en) 2004-05-27
KR20050084960A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
Ding et al. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats
KR101380446B1 (ko) 오르니틴 및 페닐아세테이트 또는 페닐부티레이트를 포함한간성 뇌병증 치료용 조성물
Steinberg et al. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model
AU763996B2 (en) Method of preventing acute lung injury
Schmidt et al. Effect of endotoxemia on intestinal villus microcirculation in rats
Herndon et al. Pulmonary injury in burned patients
HU230632B1 (hu) Gyógyszerkészítmények gyógyászati hatóanyagok szájon át történő bejuttatására
US5714469A (en) Method of treating sepsis
AU2003291367A1 (en) Method of treating sepsis-induced ards
Okada et al. Experimental study of the influence of intestinal flora on the healing of intestinal anastomoses
WO2009132149A2 (en) Treatment of conditions related to cecal ligation shock
Sigurdsson Intensive care management of acute pancreatitis
Polat et al. The effects of increased intra-abdominal pressure on bacterial translocation
Uysal et al. Comparison of effects of the tacrolimus and cyclosporine A on the colon anastomosis recovery of rats
Yilmazlar et al. Efficacy of tenoxicam on intra-abdominal adhesion prevention in a rat model
Bora et al. Short-term protective effect of octreotide on the lungs of rats with experimentally induced sepsis
Okay et al. N-acetylcysteine attenuates bacterial translocation after partial hepatectomy in rats
Gooding et al. Safety and efficacy of intravenous immunoglobulin prophylaxis in pediatric head trauma patients: a double-blind controlled trial
Fick et al. A surgical model of fulminant hepatic failure in the rabbit: different effects of end-to-side versus small-diameter side-to-side portacaval shunt
JPS648603B2 (enExample)
Bothin et al. The role of the gastrointestinal microflora in postsurgical adhesion formation–a study in germfree rats
EP1908473A1 (en) Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli
Sevastianos et al. Pathogenesis, diagnosis and therapy of infections complicating patients with chronic liver disease
BORCSTRÖM et al. Healing of colon anastomoses: an experimental study in the rabbit
SMITH The Noble plication procedure: application to acute and chronic recurrent small bowel obstruction

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application